APOE and hyperlipidemia: In order to fill this gap and to pinpoint cell-specific effects of ACKR3, we developed adipocyte and hepatocyte-specific ACKR3-deficient mice on an Apoe−/− background, which are prone to develop hyperlipidemia on WD, to determine whether ACKR3 can alter tissue lipid levels.